July 27, 2020 – Hologic Inc. was awarded an undefinitized contract action with a ceiling of $7.6 million from U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DOD) to expand production of custom sample collection and processing consumables for COVID-19 testing.
This investment will increase Hologic’s production from 4.8 million COVID-19 tests per month to 6.8 million tests per month. Hologic Inc. is expected to deliver the increased volume of consumables to market by January 2021.
The unprecedented demand for molecular diagnostic testing driven by the COVID-19 pandemic had exceeded Hologic Inc.’s production capacity for sample collection and processing consumables. However, the company is now positioned to support the demand for COVID-19 testing in the U.S. due to the installed base of more than 1,100 fully automated, high throughput Panther and Panther Fusion systems. These Panther systems are each capable of performing more than 1,000 tests in a 24-hour period, the company says.
According to the agency, the tube, cap, and multi-tube unit consumables are critical for performing molecular diagnostic tests on the Panther and Panther Fusion systems.
